Pluristem Therapeutics Inc (PSTI)

[micanwait]

Many treatments for Corona are being developed.

This one, which has already been approved in emergency situations in the US, will cost about $20 per patient and has been highly effective. I doubt PSTI's solution can compete with that.

https://techstartups.com/2020/03/28/dr-vladimir-zelenko-now-treated-699-coronavirus-patients-100-success-using-hydroxychloroquine-sulfate-zinc-z-pak-update/

Here is the approval link:

https://thehill.com/homenews/administration/490110-fda-issues-emergency-use-authorization-for-anti-malaria-drugs-amid

The PSTI cells may have a niche function --- for the small percentage of patients who get so ill that their lungs are badly damages. Perhaps the PSTI cells will have the benefit of repairing the lung tissue.
However, I doubt this will be a huge financial gain that will rescue this company. Still, it may provide the proof of concept that would be so helpful in other diseases where tissue is damaged.